Literature DB >> 6156142

Problems of terminal head and neck cancer patients.

D P Shedd, A Carl, C Shedd.   

Abstract

In recent years, there has been increased interest in defining what constitutes good quality of care for the terminal cancer patient. Progress in this area depends upon adequate knowledge of the problems in the terminal period for patients with cancer in specific sites. The present study is a survey of the final period of life in 60 head and neck cancer patients. The average survival time from diagnosis to death was 17.2 months. The mean time of hospitalization was 4 months. Pain was a problem in 85% of the patients, with feeding problems in 62% and respiratory difficulties in 43%. Eighty-six percent of the patients died in a hospital setting, with the average duration of the final hospitalization being 68 days. Our analysis documents the complex problems in the terminal phase of a head and neck cancer patient's life. These problems challenge medical facilities caring for such patients to develop programs that will provide the best possible levels of care for head and neck cancer patients and to develop approaches that will reduce the suffering experienced by the patient's family.

Entities:  

Mesh:

Year:  1980        PMID: 6156142     DOI: 10.1002/hed.2890020606

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  8 in total

1.  Quality of dying in head and neck cancer patients: the role of surgical palliation.

Authors:  Jimmy Yu Wai Chan; Victor Shing Howe To; Stanley Tien Sze Wong; William Ignace Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-05       Impact factor: 2.503

2.  Analgesia targeting IB4-positive neurons in cancer-induced mechanical hypersensitivity.

Authors:  Yi Ye; Dongmin Dang; Chi T Viet; John C Dolan; Brian L Schmidt
Journal:  J Pain       Date:  2012-04-05       Impact factor: 5.820

3.  Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice.

Authors:  Phuong N Quang; Brian L Schmidt
Journal:  J Pain       Date:  2010-01-13       Impact factor: 5.820

4.  The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain.

Authors:  John C Dolan; David K Lam; Stacy H Achdjian; Brian L Schmidt
Journal:  J Neurosci Methods       Date:  2010-01-21       Impact factor: 2.390

5.  Peripheral cannabinoids attenuate carcinoma-induced nociception in mice.

Authors:  Andre V Guerrero; Phuong Quang; Nusi Dekker; Richard C K Jordan; Brian L Schmidt
Journal:  Neurosci Lett       Date:  2008-01-08       Impact factor: 3.046

6.  Concerns, coping and quality of life in head and neck cancer patients.

Authors:  S K Chaturvedi; A Shenoy; K M Prasad; S M Senthilnathan; B S Premlatha
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

7.  Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice.

Authors:  Phuong N Quang; Brian L Schmidt
Journal:  Pain       Date:  2010-03-04       Impact factor: 7.926

8.  Symptom Burden and Quality of Life in Advanced Head and Neck Cancer Patients: AIIMS Study of 100 Patients.

Authors:  Ajeet Kumar Gandhi; Soumyajit Roy; Alok Thakar; Atul Sharma; Bidhu Kalyan Mohanti
Journal:  Indian J Palliat Care       Date:  2014-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.